May 5th - 2022
Presentations at the SEUD 2022
Pelvipharm at the 8th SEUD congress 2022 (Society of Endometriosis and Uterine Disorders), May 18–21, 2022.
- Rana Assaly will present in poster session: "Establishment of a rodent model of endometriosis to
evaluate the effect of new therapeutic strategies."
S. Compagnie, M. Bracconi, P. Muthan, F. Giuliano, D. Behr-Roussel and R. Assaly.
Please come and see us, we will be happy to discuss our results with you and potential applications for you.
February 14th - 2022
Recently accepted paper in Toxins
BoNT/A1 Secondary Failure for the Treatment of Neurogenic Detrusor Overactivity: An Ex Vivo Functional Study
Jacquie Maignel, Vincent Martin, Rana Assaly, Mathieu L. Vogt, Kevin Retailleau, Alexandra Laugerotte, Stéphane Lezmi, Pierre Denys, Johannes Krupp and Charles Joussain
Toxins 2022, 14(2), 77
February 15th - 2022
Presentations at the Virtual ESSM 2022
- Rana Assaly will present in video session: "Prolonged pro-erectile
facilitator effect of LIB-01 in anesthetized Wistar rats."
M. Razanakolona, C. Bradesi, M. Laurin, K. Fugl-Meyer, D. Behr-Roussel, F. Giuliano and R. Assaly
- François Giuliano will present in video session: "Intracavernosal onabotulinumtoxinA exerts a synergistic pro-erectile effect when combined with sildenafil in spontaneously hypertensive rats"
F. Giuliano, C. Joussain1, P. Denys, M. Laurin, D. Behr-Roussel and R. Assaly
- François Giuliano will present in digital poster area: "Long term effectiveness and safety of intracavernosal botulinum toxin a as an add-on therapy tophosphosdiesterase type 5 inhibitors or prostaglandin e1 injections for erectile dysfunction – a case series study" (#169)
F. Giuliano, C. Joussain, P. Denys
Please come and see us, we will be happy to discuss our results with you and potential applications for you.
January 15th - 2022
Best Wishes 2022